About
David Reese is the Executive Vice President of Research and Development at Amgen. He previously worked as the Senior Vice President of Translational Sciences responsible for Medical Sciences, Comparative Biology and Safety Sciences, and Pharmacokinetics and Drug Metabolism. Prior to assuming this role, Reese was vice president of Translational Sciences and therapeutic area head for Oncology Global Development. Reese joined Amgen in 2005 and served in various roles in Global Development and Medical Sciences. Prior to joining Amgen, Reese was director of Clinical Research for the Breast Cancer International Research Group (BCIRG) and a co-founder, president and chief medical officer of Translational Oncology Research International (TORI), a not-for-profit academic clinical research organization. Reese is a graduate of Harvard College and the University of Cincinnati College of Medicine. He completed training in Internal Medicine and Hematology/Oncology at the University of California,
Position in the VCSift Database
- • 8 investors at Amgen are tracked.
- • 1 investors hold the Executive Vice President, Research and Development role in VCSift. David M. Reese is one of them.
- • 10 investors are based in Ventura, California, United States.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- Ventura, US
Contact Information
Find more investors like David M.
Search Investors